MoneyWorks4Me

Sanofi India board to consider unaudited financial results

15 Jul 2020 Evaluate

Sanofi India has informed that pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company will be held on Tuesday, 28th July 2020 to consider the unaudited financial results for the quarter and half year ended 30th June 2020 (Q2).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..